摘要
低剂量过敏原免疫疗法（LDA）是一种替代性过敏治疗方案，通过将极度稀释的过敏原与特定酶相结合，训练免疫系统对过敏原产生耐受。据报道，该疗法成功率高达91%，适用范围远超普通过敏症。Berg博士将其作为一种选择，推荐给那些通过饮食调整等基础方法仍未获得缓解的人群。
核心要点
- Low Dose Allergen Immunotherapy（LDA） 据报道在多种病症中拥有 91% 的成功率
- LDA 使用极度稀释的过敏原，浓度低至 十亿亿分之一，概念上与 homeopathy 相似
- 该疗法通过 皮下注射（注射于皮肤下，而非直接入血）方式给药
- 关键成分是酶 β-葡萄糖醛酸苷酶（beta-glucuronidase），它向免疫系统发出信号，使其对过敏原产生耐受而非发生反应
- LDA 是与免疫系统协同作用，而非抑制免疫，因此据报道副作用极少
- 在考虑 LDA 之前，Berg 博士建议先通过饮食调整和 intermittent fasting 等基础方法应对过敏
- LDA 所适用的病症范围出人意料地广泛，包括自身免疫症状、神经系统疾病及皮肤病
详细内容
什么是 LDA？
Low Dose Allergen Immunotherapy（LDA）是一种替代性过敏治疗方案，以超低浓度将种类极为广泛的过敏原混合物暴露于免疫系统。与传统 allergy immunotherapy 采用逐步递增特定过敏原剂量的方式不同，LDA 的稀释浓度极端，最低可达：
- 千万分之一
- 十亿亿分之一
这些浓度远低于标准过敏注射方案，原理上更接近 homeopathy。
β-葡萄糖醛酸苷酶的作用
LDA 的独特之处在于在过敏原混合物中加入了酶 beta-glucuronidase。该酶被认为是指导免疫系统忽略或耐受过敏原、而非引发炎症反应的关键机制。这与单纯抑制免疫活性的治疗方式有本质区别——LDA 的目的是自然地重塑免疫行为。
LDA 可能适用的病症
LDA 被认为适用于多种病症：
- 呼吸系统/环境性： hay fever、尘螨 allergies、sinusitis、asthma
- 皮肤： hives、psoriasis、eczema
- 过敏敏感： 化学物质敏感
- 自身免疫相关症状
- 神经/行为： ADHD、autism spectrum
- 消化系统： IBS（肠易激综合征）
- 疼痛/神经： migraine headaches
基础干预建议
在考虑 LDA 之前，建议先尝试基础干预措施，这些措施本身可能就足以缓解过敏：
- 饮食调整（具体方案在原文中有所提及，但内容不够清晰）
- Intermittent fasting——被强调为减轻过敏反应的潜在有效工具
安全性
LDA 被认为副作用极少，这归因于超低剂量以及基于酶的天然作用机制，避免了对免疫系统的抑制。
相关概念
- Low Dose Allergen Immunotherapy
- intermittent fasting
- homeopathy
- allergy immunotherapy
- hay fever
- sinusitis
- asthma
- hives
- psoriasis
- eczema
- IBS
- ADHD
- migraine headaches
- autoimmune response
- immune tolerance
English Original 英文原文
Summary
Low Dose Allergen Immunotherapy (LDA) is an alternative treatment for allergies that uses extremely diluted allergens combined with a specific enzyme to train the immune system to tolerate triggers. It reportedly has a 91% success rate and applies to a wide range of conditions beyond typical allergies. Dr. Berg presents it as an option for people who haven’t found relief through foundational approaches like diet changes.
Key Takeaways
- Low Dose Allergen Immunotherapy (LDA) has a reported 91% success rate across a broad range of conditions
- LDA uses allergens diluted to extreme concentrations — as low as one part per one quadrillion — making it conceptually similar to homeopathy
- The treatment is administered via subcutaneous injection (under the skin, not into a bloodstream)
- The critical component is the enzyme beta-glucuronidase, which signals the immune system to tolerate rather than react to allergens
- LDA works with the immune system, not by suppressing it, resulting in reportedly low side effects
- Before pursuing LDA, Dr. Berg recommends addressing allergies first through Electrolytes 电解质 (likely “Electrolytes 电解质” was meant as “allergy taquito” appears to be a transcription error — he references a foundational dietary approach) and intermittent fasting
- LDA addresses a surprisingly wide range of conditions, including autoimmune symptoms, neurological conditions, and skin disorders
Details
What Is LDA?
Low Dose Allergen Immunotherapy (LDA) is an alternative allergy treatment that exposes the immune system to an extremely broad mixture of allergens at ultra-low concentrations. Unlike conventional allergy immunotherapy, which uses progressively increasing doses of specific allergens, LDA works at dilutions as extreme as:
- 1 part per 10 million
- 1 part per 1 quadrillion
These concentrations are far below standard allergy shot protocols and are closer in principle to homeopathy.
The Role of Beta-Glucuronidase
The distinguishing feature of LDA is the addition of the enzyme beta-glucuronidase to the allergen mixture. This enzyme is described as the mechanism by which the immune system is instructed to ignore or tolerate the allergens rather than mount an inflammatory response. This is a key distinction from treatments that simply suppress immune activity — LDA is designed to retrain immune behavior naturally.
Conditions LDA May Help
LDA is noted as applicable to a wide spectrum of conditions:
- Respiratory/Environmental: hay fever, dust mite allergies, sinusitis, asthma
- Skin: hives, psoriasis, eczema
- Sensitivities: chemical sensitivities
- Autoimmune-related symptoms
- Neurological/Behavioral: ADHD, autism spectrum
- Digestive: IBS (irritable bowel syndrome)
- Pain/Neurological: migraine headaches
First-Line Recommendations
Before pursuing LDA, foundational interventions are suggested that may resolve allergies on their own:
- Dietary approach (specific protocol referenced but unclear from transcript)
- Intermittent fasting — highlighted as a potentially powerful tool for reducing allergic responses
Safety Profile
LDA is noted to have very low side effects, attributed to both the ultra-low dosing and the natural, enzyme-based mechanism that avoids immune suppression.
Mentioned Concepts
- Low Dose Allergen Immunotherapy
- intermittent fasting
- homeopathy
- allergy immunotherapy
- hay fever
- sinusitis
- asthma
- hives
- psoriasis
- eczema
- IBS
- ADHD
- migraine headaches
- autoimmune response
- immune tolerance